Argenica Therapeutics' Phase 2 stroke drug trial hits major milestone

By Proactive Investors / November 06, 2024 / www.youtube.com / Article Link


Argenica Therapeutics Ltd (ASX:AGN, OTC:OTCMKTS: AGNTF) CEO and managing director, Dr Liz Dallimore talked with ...

Recent News

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com

Newmont's Q1/26 earnings surge again even on production drop

April 27, 2026 / www.canadianminingreport.com

Mining still rules market over past six months

April 20, 2026 / www.canadianminingreport.com

Inventories for aluminum decline, for copper surge

April 20, 2026 / www.canadianminingreport.com

Major new entrants to large cap TSXV gold stocks

April 13, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok